ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test 'Off-the-Shelf' cell therapy that may outlast cancer
Disease control Recruiting nowThis study is testing a new type of cell therapy for adults whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to standard treatments. Doctors take immune cells from healthy donors, genetically modify them to better target and fight leukemia cells, and in…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Scientists supercharge Patient's own cells to hunt blood cancers
Disease control Recruiting nowThis early-stage study is testing a new treatment for people whose lymphoma or leukemia has returned or hasn't responded to standard therapies. Doctors take a patient's own immune cells (T-cells), genetically modify them in a lab to better recognize and attack cancer cells, and t…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Double-Punch CAR-T trial offers hope for kids with Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing a new, experimental CAR-T cell therapy designed to fight two targets (CD19 and CD22) on cancer cells at once. It is for children and young adults (ages 3-39) whose B-cell leukemia or lymphoma has come back or hasn't responded to standard treatments. Doctors …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for kids with tough cancers: testing a promising drug
Disease control Recruiting nowThis study is testing a drug called ponatinib in children and teenagers (ages 1 to 18) whose cancers have come back or have not responded to standard treatments. The main goals are to find a safe dose and see if the drug can help control various advanced cancers, including leukem…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences International Sàrl • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Double-Donor transplant offers hope for leukemia patients lacking matches
Disease control Recruiting nowThis study is testing a new transplant method for adults with high-risk leukemia or myelodysplastic syndromes (MDS) who do not have a perfectly matched donor. It combines cells from a partially matched family donor with cells from umbilical cord blood. The goal is to see if this …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
Testing a liquid lifeline for kids who Can't swallow pills
Knowledge-focused Recruiting nowThis study aims to understand how children's bodies process a liquid form of the cancer drug venetoclax, which is made by crushing tablets. It involves 30 children and young adults with blood cancers who cannot swallow pills and are already receiving this liquid medicine as part …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
New scan aims to spot hidden cancer cells
Knowledge-focused Recruiting nowThis study is testing a new type of imaging scan to see if it can find leftover cancer cells in people with leukemia or myeloma. Researchers want to know if the scan results match up with other standard lab tests. The goal is to see if this scan could one day help doctors better …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Major cancer centers launch massive transplant tracking project
Knowledge-focused Recruiting nowThis study collects health information from patients receiving stem cell transplants for various blood cancers and immune disorders. Researchers will track 2,000 patients over time to gather data on survival rates and treatment complications. The goal is to build a comprehensive …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC